PTIX Protagenic Therapeutics, Inc.
USHealthcareAs of 2026-07-02
Why PTIX matters now
Protagenic Therapeutics, Inc. (PTIX) is a US stock in Healthcare. The latest InvestLog snapshot shows $0.23 with -34.29% on the session and $416.3K in market capitalization; recent performance reads 1-month -36.92% and YTD -68.46%.
The latest financial table shown here is Q4 2025, with revenue of $0.00, net income of $2.2M, and EPS of $1.14. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -557.9%.
The latest indexable market news headline is "Protagenic Therapeutics' Lead Candidate PT00114 Attenuated Chronic Stress Responses in a Well-Established Rodent Model" from Accesswire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $—. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
-0.33
P/S
0.00
EV/EBITDA
-0.21
DCF Value
$-1.43
FCF Yield
-557.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
184.9%
ROA
-241.8%
ROIC
379.7%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $0.00 | $2.2M | $1.14 |
| FY 2025 | $0.00 | $-5.2M | $-3.45 |
| Q3 2025 | $0.00 | $-869.5K | $-0.47 |
| Q2 2025 | $0.00 | $-5.1M | $-1.37 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
—
Beta
0.47
Protagenic Therapeutics, Inc. operates as a biopharmaceutical firm dedicated to the research and development of novel treatments designed to address neuropsychiatric and mood conditions exacerbated by stress. Foremost among its investigational products is PT00114, a laboratory-synthesized version of the teneurin carboxy-terminal associated peptide. This compound functions by emulating an innate brain signaling peptide, known for its ability to temper exaggerated stress reactions. The company's headquarters are located in New York, New York.